Wang, S., Hong, S., Yang, J., Qian, J., Zhang, X., Shpall, E., . . . Yi, Q. (2006). Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. The American Society of Hematology.

Wang, Siqing, Sungyoul Hong, Jing Yang, Jianfei Qian, Xiang Zhang, Elizabeth Shpall, Larry W. Kwak, and Qing Yi. Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patients' Monocyte-derived Dendritic Cells By Inhibiting P38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in Progenitor Cells. The American Society of Hematology, 2006.

Wang, Siqing, et al. Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patients' Monocyte-derived Dendritic Cells By Inhibiting P38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in Progenitor Cells. The American Society of Hematology, 2006.